Cassidy Bio is an AI-first biotechnology company building the first programmable platform for gene editing. Cassidy Bio replaces the narrow, trial-and-error design process with large-scale prediction, simulation, and in silico validation, powered by genomic foundation models trained on proprietary biological data. The platform scales to connect across multiple components

guides, editing systems, delivery systems and variant backgrounds ranking designs by safety and efficacy. Cassidy Bio’s vision is to enable not just one-off miracles, but a new generation of reliable gene editing therapies at scale.